Morphic Therapeutics

Scroll
Investment area
Novo Ventures
Region
Western USA
Date of investment
September 2018
Website
https://morphictx.com/

Morphic Therapeutics is leading the development of a new generation of oral integrin drug with advancing preclinical programs in autoimmunity, fibrosis, vascular disorders and immune-oncology.